药物输送 SCIE

期刊简介预计审稿时间： 约3.0个月

Drug Delivery is an open access journal serving the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.

《药物输送》是一本开放获取期刊，服务于学术界和工业界，其内容涵盖了药物输送和分子、细胞及更高水平靶向的基础研究、开发和应用原理，并经过同行评审。涵盖的主题包括所有输送系统，包括口服、肺部、鼻腔、肠外和透皮，以及进入方式，例如控释系统；微胶囊、脂质体、囊泡和大分子结合物；抗体靶向；蛋白质/肽输送；DNA、寡核苷酸和 siRNA 输送。除非与原始药物输送问题直接相关，否则不会考虑有关药物剂型及其优化的论文。已发表的文章介绍了原创研究和批判性评论。

《Drug Delivery》(药物输送)编辑部通讯方式为TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。